Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decorin for PVR Prevention in Perforating Injuries
NCT02865031Phase 2Completed
- Sponsor
- Cairo University
- Start
- Aug 2015
- Primary completion
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of decorin in Proliferative Vitreoretinopathy (PVR), sponsored by Cairo University. Started Aug 2015; status: completed.
02
Drugs
decorin
03
Conditions
Proliferative Vitreoretinopathy (PVR)
Beyond the preview
Go deeper on NCT02865031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02865031.